Aspirin Use for the Primary Prevention of Cardiovascular Disease in the Elderly

Author： Sarbacker G. Blair   Lusk Kathleen A.   Flieller Lauren A.   Van Liew Jeffrey R.  

Publisher： American Society of Consultant Pharmacists

ISSN： 0888-5109

Source： The Consultant Pharmacist, Vol.31, Iss.1, 2016-01, pp. : 24-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspirin for Primary Prevention of Cardiovascular Events in the Elderly: Current Status and Future Directions

By Ward Stephanie A.   Demos Lisa  

Drugs & Aging, Vol. 29, Iss. 4, 2012-04 ,pp. : 251-258

Adis International

Access to resources Recommend Favorite

Statins for the Primary Prevention of Cardiovascular Disease in the Elderly

By  

The Consultant Pharmacist, Vol. 30, Iss. 1, 2015-01 ,pp. : 20-30

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Aspirin for the Prevention of Cardiovascular Events in the Elderly

By Mahé I.  

Drugs & Aging, Vol. 20, Iss. 13, 2003-01 ,pp. : 999-1010

Adis International

Access to resources Recommend Favorite

Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis

By Younis Naveed   Williams Steven   Ammori Basil   Soran Handrean  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1459-1466

Informa Healthcare

Access to resources Recommend Favorite

Rationale for a Trial of Low-Dose Aspirin for the Primary Prevention of Major Adverse Cardiovascular Events and Vascular Dementia in the Elderly: Aspirin in Reducing Events in the Elderly (ASPREE)

By Nelson M.R.   Reid C.M.  

Drugs & Aging, Vol. 20, Iss. 12, 2003-01 ,pp. : 897-903

Adis International

Access to resources Recommend Favorite